fostamatinib

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents

Novel Experimental COVID-19 Therapies Affecting Host Response

Special Drug Use-results Survey for Long-term Use (Fostamatinib)

Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa

Fostamatinib for Hospitalized Adults With COVID-19